Sweden: Market for Other Medicaments For Therapeutic Or Prophylactic Uses 2024

Market Size for Other Medicaments For Therapeutic Or Prophylactic Uses in Sweden

In 2022, the Swedish market for other medicaments for therapeutic or prophylactic uses decreased by X% to $X, falling for the third year in a row after two years of growth. Overall, consumption saw a deep slump. Consumption of peaked at $X in 2013; however, from 2014 to 2022, consumption stood at a somewhat lower figure.

Production of Other Medicaments For Therapeutic Or Prophylactic Uses in Sweden

In value terms, production of other medicaments for therapeutic or prophylactic uses surged to $X in 2022 estimated in export price. Overall, production, however, showed a deep slump. The growth pace was the most rapid in 2019 when the production volume increased by X%. Over the period under review, production of hit record highs at $X in 2012; however, from 2013 to 2022, production remained at a lower figure.

Exports of Other Medicaments For Therapeutic Or Prophylactic Uses

Exports from Sweden

In 2022, overseas shipments of other medicaments for therapeutic or prophylactic uses increased by X% to X tons, rising for the third consecutive year after three years of decline. Overall, exports enjoyed a buoyant expansion. The growth pace was the most rapid in 2021 when exports increased by X% against the previous year. Over the period under review, the exports of reached the maximum in 2022 and are expected to retain growth in the immediate term.

In value terms, exports of other medicaments for therapeutic or prophylactic uses declined markedly to $X in 2022. In general, exports, however, saw a pronounced setback. The growth pace was the most rapid in 2019 with an increase of X% against the previous year. The exports peaked at $X in 2012; however, from 2013 to 2022, the exports remained at a lower figure.

Exports by Country

Greece (X tons) was the main destination for exports of other medicaments for therapeutic or prophylactic uses from Sweden, accounting for a X% share of total exports. Moreover, exports of other medicaments for therapeutic or prophylactic uses to Greece exceeded the volume sent to the second major destination, Turkey (X tons), more than tenfold. The third position in this ranking was taken by Norway (X tons), with a X% share.

From 2012 to 2022, the average annual growth rate of volume to Greece amounted to X%. Exports to the other major destinations recorded the following average annual rates of exports growth: Turkey (X% per year) and Norway (X% per year).

In value terms, Turkey ($X) remains the key foreign market for other medicaments for therapeutic or prophylactic uses exports from Sweden, comprising X% of total exports. The second position in the ranking was held by Greece ($X), with a X% share of total exports. It was followed by Norway, with a X% share.

From 2012 to 2022, the average annual growth rate of value to Turkey stood at X%. Exports to the other major destinations recorded the following average annual rates of exports growth: Greece (X% per year) and Norway (X% per year).

Export Prices by Country

In 2022, the average export price for other medicaments for therapeutic or prophylactic uses amounted to $X per ton, shrinking by X% against the previous year. Overall, the export price showed a abrupt decline. The pace of growth was the most pronounced in 2017 when the average export price increased by X%. The export price peaked at $X per ton in 2019; however, from 2020 to 2022, the export prices remained at a lower figure.

Prices varied noticeably by country of destination: amid the top suppliers, the country with the highest price was Italy ($X per ton), while the average price for exports to Greece ($X per ton) was amongst the lowest.

From 2012 to 2022, the most notable rate of growth in terms of prices was recorded for supplies to Denmark (X%), while the prices for the other major destinations experienced more modest paces of growth.

Imports of Other Medicaments For Therapeutic Or Prophylactic Uses

Imports into Sweden

In 2022, supplies from abroad of other medicaments for therapeutic or prophylactic uses decreased by X% to X tons, falling for the second consecutive year after three years of growth. Over the period under review, imports showed a sharp curtailment. The pace of growth appeared the most rapid in 2018 with an increase of X% against the previous year. Over the period under review, imports of hit record highs at X tons in 2013; however, from 2014 to 2022, imports failed to regain momentum.

In value terms, imports of other medicaments for therapeutic or prophylactic uses fell to $X in 2022. Overall, imports showed a noticeable descent. The pace of growth was the most pronounced in 2018 with an increase of X%. Imports peaked at $X in 2020; however, from 2021 to 2022, imports failed to regain momentum.

Imports by Country

France (X tons), Belgium (X tons) and the UK (X tons) were the main suppliers of imports of other medicaments for therapeutic or prophylactic uses to Sweden, together accounting for X% of total imports.

From 2012 to 2022, the most notable rate of growth in terms of purchases, amongst the main suppliers, was attained by Belgium (with a CAGR of X%), while imports for the other leaders experienced a decline.

In value terms, Belgium ($X), Germany ($X) and France ($X) were the largest other medicaments for therapeutic or prophylactic uses suppliers to Sweden, together accounting for X% of total imports.

In terms of the main suppliers, Belgium, with a CAGR of X%, saw the highest rates of growth with regard to the value of imports, over the period under review, while purchases for the other leaders experienced more modest paces of growth.

Import Prices by Country

In 2022, the average import price for other medicaments for therapeutic or prophylactic uses amounted to $X per ton, stabilizing at the previous year. In general, the import price posted a significant expansion. The growth pace was the most rapid in 2021 when the average import price increased by X%. Over the period under review, average import prices attained the peak figure in 2022 and is likely to see steady growth in years to come.

There were significant differences in the average prices amongst the major supplying countries. In 2022, amid the top importers, the country with the highest price was Germany ($X per ton), while the price for Italy ($X per ton) was amongst the lowest.

From 2012 to 2022, the most notable rate of growth in terms of prices was attained by China (X%), while the prices for the other major suppliers experienced more modest paces of growth.

Source: IndexBox Platform

Frequently Asked Questions (FAQ) :